NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

if you go back to the ASM, what LP really said was that they’d not be updating interactions or back and forths

Ah, okay, that's what she said. She didn't say this:

So we, the typical thing, we are gonna follow the typical practice of biotech and pharma companies, which is, we are not going to provide interim step blow by blow. They asked us this, we answered that. They asked us the next thing, we answer that. No, we’re not gonna do the interim steps. We're just going to tell the result when the process is finished. That's the typical approach, and that's the approach that we're gonna be taking. Okay. That's our big priority area, of course.

Got it, thanks for clearing that up for me.